 |
PDBsum entry 1z0h
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.69
- bontoxilysin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochem Biophys Res Commun
330:97
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B.
|
|
S.Jayaraman,
S.Eswaramoorthy,
S.A.Ahmed,
L.A.Smith,
S.Swaminathan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Botulinum neurotoxins comprise seven distinct serotypes (A-G) produced by
Clostridium botulinum. The crystal structure of the binding domain of the
botulinum neurotoxin type B (BBHc) has been determined to 2A resolution. The
overall structure of BBHc is well ordered and similar to that of the binding
domain of the holotoxin. However, significant structural changes occur at what
would be the interface of translocation and binding domains of the holotoxin.
The loop 911-924 shows a maximum displacement of 14.8A at the farthest point.
The N-terminal helix reorients and moves by 19.5A from its original position.
BBHc is compared with the binding domain of the holotoxin of botulinum type A
and B, and the tetanus C-fragment to characterize the heavy chain-carbohydrate
interactions. The probable reasons for different binding affinity of botulinum
and tetanus toxins are discussed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Montal
(2010).
Botulinum neurotoxin: a marvel of protein design.
|
| |
Annu Rev Biochem,
79,
591-617.
|
 |
|
|
|
|
 |
N.Gul,
L.A.Smith,
and
S.A.Ahmed
(2010).
Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.
|
| |
PLoS One,
5,
e12872.
|
 |
|
|
|
|
 |
P.Stenmark,
M.Dong,
J.Dupuy,
E.R.Chapman,
and
R.C.Stevens
(2010).
Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
|
| |
J Mol Biol,
397,
1287-1297.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Stenmark,
J.Dupuy,
A.Imamura,
M.Kiso,
and
R.C.Stevens
(2008).
Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction.
|
| |
PLoS Pathog,
4,
e1000129.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Jin,
A.Rummel,
T.Binz,
and
A.T.Brunger
(2006).
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
|
| |
Nature,
444,
1092-1095.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |